Analysis of carbapenem resistance genes in Acinetobacter baumannii isolates from Kuwait hospitals
Abstract number: P1302
Al-Sweih N., Al-Hubail M., Rotimi V.O.
Objectives: This study was designed to investigate the molecular epidemiology and genetic basis of the carbapenem resistance in clinical isolates of Acinetobacter baumannii obtained from all government hospitals in Kuwait.
Methods: A total of 250 clinical isolates were collected from 8 hospitals. Their susceptibility to 18 antibiotics was determined by E test method. Carbapenems resistant isolates were screened for phenotypic MBL production by disk approximation test (DAT) and MBL E test. Genetic characterization of the resistant mechanisms was performed by PCR. Their clonal relatedness was assessed by PFGE.
Results: All the isolates were multidrug resistant. Of the 250 isolates, 93 (37.2%) were resistant to carbapenems. The prevalence of MBL-producing isolates was 74.2% and 57% by DAT and MBL Etest, respectively. Sixty-five (69.9%) of the carbapenem-resistant isolates were positive for one or more resistance genes; 37 were positive for blaIMP-1, 17 blaVIM-1, 43 blaVIM2, 24 blaSPM-1, 32 blaOXA-23, 1 blaOXA-24. PFGE demonstrated widespread clones of similar strains in different hospitals and a cluster of 3 clones found only in one particular hospital.
Conclusion: Resistance clinical isolates to carbapenem has reached unacceptable levels in Kuwait and MBLs, as well as oxacilinases, are highly prevalent among A. baumannii in our hospitals.
Acknowledgment: This work was supported by a Kuwait University Research Grant no. YM 01/08 which is gratefully acknowledged.
|Session name:||Abstracts 20th European Congress of Clinical Microbiology and Infectious Diseases|
|Location:||Vienna, Austria, 10 - 13 April 2010|
|Back to top|